Developer docs
API playgroundTry for free, no card

Search company profiles

Bioquell

Full company profile

uuid002ytkw

Namestring
Bioquell
Legal namestring
Bioquell Group (Bioquell PLC)
Websiteurl
bioquell.com
Company typeenum
Private
Founded yearint
2003
Descriptiontext

Bioquell designs, manufactures, and services bio-decontamination systems based on proprietary 35% Hydrogen Peroxide Vapor (HPV) technology. The HPV process is a four-stage cycle (Preparation, Vaporization, Dwell, Aeration) that achieves a validated 6-log sporicidal kill on exposed surfaces while leaving no residue, allowing equipment to be immediately operational without post-cycle wipe-down. Bioquell's product range includes mobile and fixed HPV generators (ProteQ, L-4, IG-2, SeQure), the customizable Qube polypropylene pharmaceutical isolator with a 16-week install/validation cycle, and the Integrated Building Decontamination System (IBDS) for centralized facility-level decontamination via HVAC distribution and BMS integration. The portfolio is EPA-registered, BPR-compliant, GMP-aligned, and supports 21 CFR Part 11 audit trails, with consumables (RFID-tagged 35% hydrogen peroxide sterilant and in-house Geobacillus stearothermophilus biological indicators) sold alongside the hardware estate.

Bioquell serves pharmaceutical manufacturing and compounding, biotechnology and drug development, gene and cell therapy, hospitals and patient care, and research laboratories. End users include pharma manufacturers operating GMP/GLP cleanrooms, advanced therapy manufacturers handling cell and gene material, and NHS hospitals using the service for infection prevention and outbreak response. The company also publishes over 50 peer-reviewed references and offers a free contamination control webinar series targeting cell and gene therapy manufacturers.

The business operates three revenue streams: (1) equipment and systems sales (ProteQ, Qube, SeQure, L-4, IG-2, IBDS); (2) recurring consumables (hydrogen peroxide sterilant, biological and chemical indicators); and (3) professional services including the Rapid Bio-Decontamination Service (RBDS) for on-site managed decontamination and validation services (IQ/OQ, customized cycle development). Go-to-market is enterprise field sales via wholly-owned subsidiaries in seven countries (UK, USA, France, Germany, Ireland, China, Singapore) under the Ecolab Life Sciences brand, complemented by the QuAD Quality Assurance Data Portal for digital cycle and compliance documentation. Bioquell is a wholly-owned subsidiary of Ecolab Inc., and pricing is not publicly disclosed — customers are directed to regional sales teams for quotes.

Short descriptiontext

Bioquell designs, manufactures, and services Hydrogen Peroxide Vapor (HPV) bio-decontamination systems, isolators, and on-site decontamination services for pharmaceutical manufacturing, biotechnology, gene and cell therapy, hospital infection control, and life sciences research, operating as a wholly-owned subsidiary of Ecolab Inc.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
251–500
akta.pro rankint
HeadquartersAndover, United Kingdom
HQ citystring
Andover
HQ countrystring
United Kingdom
HQ regionstring
Europe
Markets served

Serves global market

Offices7 records

Each record includes

City, Country, Type, Description, Source

Keyword5 values
hydrogen peroxide vapor, bio-decontamination systems, pharmaceutical contamination control, cleanroom decontamination services, aseptic manufacturing solutions
Industry4 codes
1Bioprocess Safety, Biosafety & Contamination Control Solutions (single-use integrity, environmental monitoring)
CodeHLAAAJAOPrimaryYes
2Bioprocess Consumables & Reagents (resins, membranes, media components, buffers)
CodeHLAAAJAIPrimaryNo
3Infectious Disease/Pathogen Decontamination
CodeHSAEAHAFPrimaryNo
4Biohazard Spill Response & Decontamination Services
CodeBPALAGAHPrimaryNo
NAICS code1 code
  • Irradiation Apparatus Manufacturing334517
SIC code1 code
  • Surgical & Medical Instruments & Apparatus3841
Product category
Bio-decontamination Equipment
Social media profiles2 records
GTM motion1 record

Each record includes

Type, Description, Source

Revenue model3 records
1Equipment and Systems Sales
TypeHardware Sales
Description

Sale of Bioquell HPV decontamination systems including ProteQ, Qube, SeQure, L-4, IG-2, and Integrated Building Decontamination Systems. Systems are sold directly to pharmaceutical, life sciences, and healthcare facilities.

bioquell.com
2Rapid Bio-Decontamination Service (RBDS)
TypeProfessional Services
Description

On-site decontamination services provided by skilled Bioquell personnel for facilities that do not have resources, time, or equipment. Service includes full reporting with biological and chemical indicator results.

bioquell.com
3Consumables
TypeHardware Sales
Description

Hydrogen peroxide sterilant (35% concentration with RFID tagging), biological indicators, and chemical indicators for use with Bioquell systems. Consumables are provided in traceable bottles with certificates of analysis.

bioquell.com
Marketing channels4 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels3 records

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components6 values
Personnel, Supply Chain, Technology or R&D, Operations, Marketing or Sales, Infrastructure
GTM typeB2B
B2B
Offering typeHardware or Manufacturing
Hardware or Manufacturing
Brand1 of 8 records shown
1Bioquell Qube
Description

Pharmaceutical isolator integrated with Hydrogen Peroxide Vapor technology for sterility testing, gene & cell therapy, small batch production, compounding, and cytotoxic preparation

bioquell.com
+7 more records
Core offering1 text field

Bioquell designs, manufactures and services bio-decontamination systems based on its proprietary 35% Hydrogen Peroxide Vapor (HPV) technology, including the ProteQ mobile unit, Qube pharmaceutical isolator, SeQure, L-4, IG-2, and Integrated Building Decontamination Systems. The company also delivers the on-site Rapid Bio-Decontamination Service (RBDS) using HPV and supplies consumables (biological indicators, chemical indicators and hydrogen peroxide sterilant) plus validation services for pharmaceutical, life sciences and healthcare facilities.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 of 3 values shown
  • 99.9999% pathogen reduction (6-log kill) on all exposed surfaces
+2 more records
Product overview1 text field

Bioquell, an Ecolab company, provides a comprehensive hydrogen peroxide vapor (HPV) bio-decontamination portfolio consisting of proprietary 35% Hydrogen Peroxide Vapor technology as the core platform, supported by multiple product systems (ProteQ mobile unit, Qube isolator, SeQure fixed system, L-4 and IG-2 generators, and Integrated Building Decontamination System) and the Rapid Bio-Decontamination Service (RBDS) for managed on-site decontamination. The portfolio includes complementary consumables (biological/chemical indicators, hydrogen peroxide sterilant), validation services, and the QuAD data management portal. Products serve pharmaceutical manufacturing, life sciences R&D, healthcare, and biotech applications with EPA registration and BPR compliance.

Product and service11 records
1Bioquell ProteQ
CategoryBio-decontamination Equipment
Description

Mobile, scalable Hydrogen Peroxide Vapor generator with wireless communication technology. All components including aeration are hosted within the frame for simple setup. Designed for biopharmaceutical manufacturing areas, production labs, room and zone decontamination, bio-safety labs, cleanrooms, and GMP/GLP laboratories.

2Bioquell Qube Pharmaceutical Isolator
CategoryPharmaceutical Isolator
Description

Customizable pharmaceutical isolator integrated with Hydrogen Peroxide Vapor technology. Constructed from polypropylene (not stainless steel) for quick installation and validation within 16 weeks. Used for sterility testing, gene and cell therapy, small batch production, compounding, and cytotoxic preparation.

3Bioquell SeQure
CategoryBio-decontamination Equipment
Description

Fixed, wall-mounted bio-decontamination system for pass-throughs, material airlocks, lab and room decontamination, and spaces smaller than 150 cubic meters. Designed for viral and bacterial vector work, biosecurity and small research areas.

4Bioquell L-4
CategoryBio-decontamination Equipment
Description

Versatile, multipurpose Hydrogen Peroxide Vapor generator for enclosed systems and equipment up to larger rooms and spaces (up to 250 cubic meters with optional distribution head). Compatible with isolators, RABS, freeze dryers, bio-safety cabinets, cage and rack washers, incubators, and filter bank enclosures.

5Bioquell IG-2
CategoryBio-decontamination Equipment
Description

System integration solution for RABS, filling lines, cage and rack washers, robotic enclosures, material airlocks, and small-volume rooms. Offers remote-control screen and 21 CFR Part 11 audit trail compliance for electronic records.

6Bioquell Integrated Building Decontamination System (IBDS)
CategoryBio-decontamination Equipment
Description

Fully integrated, centralized bio-decontamination solution designed for frequent or routine decontamination of the same area. Equipment is located in unclassified area with vapor distributed through building HVAC or dedicated pipe network, controlled via Building Management System (BMS) integration. Validated 6-log sporicidal kill for GMP biopharmaceutical manufacturing, filling suites, biomedical facilities and biosafety laboratories.

7Rapid Bio-Decontamination Service (RBDS)
CategoryManaged Decontamination Service
Description

On-site managed decontamination service delivered by trained Bioquell personnel using Hydrogen Peroxide Vapor. Available for spaces from smallest enclosures to large buildings, including BSL-2/3/4 labs, post-construction commissioning, pharmaceutical production and emergency containment. Includes full reporting with biological and chemical indicators confirming 6-log sporicidal kill, cycle parameters, and environmental conditions.

8Bioquell Biological Indicators
CategoryConsumables
Description

In-house manufactured biological indicators using Geobacillus stearothermophilus endospores with over one million spores per carrier disc. Available in boxes of 20 or 100 with re-sealable wallets of 20 each for cycle validation in Bioquell decontamination systems.

9Bioquell Chemical Indicators
CategoryConsumables
Description

In-house manufactured chemical indicators with reactive dye that changes color when exposed to Hydrogen Peroxide Vapor, providing real-time cycle success indication. Available in boxes of 20 or 100 for use with Bioquell decontamination systems.

10Bioquell Hydrogen Peroxide Sterilant (HPV-AQ)
CategoryConsumables
Description

35% hydrogen peroxide sterilant solution (EPA Registration Number: 72372-1-86703) supplied in RFID-tagged bottles for traceability, volume tracking, GMP documentation and cycle reproducibility with Bioquell decontamination systems.

11Bioquell Validation Services
CategoryProfessional Services
Description

Professional validation, maintenance and customer service support including Installation and Operational Qualification (IQ/OQ), customized cycle development, and regulatory compliance verification for Bioquell decontamination systems installed at customer sites.

Scale indicator3 records

Each record includes

Type, Value, Description, Source

Partnership1 partner
Strategic tierFlagshipTypeStrategic or Co-development Partner
Description

Bioquell is a subsidiary of Ecolab Inc., operating under the Ecolab Life Sciences division. The partnership provides Bioquell with Ecolab's global distribution network, resources, and integration into a broader contamination control portfolio. Bioquell technology is marketed as part of Ecolab Life Sciences Complete Solutions.

Recent move6 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight6 records

Each record includes

Type, Description

Peers10 records
TypeBroad incumbent
Description

Getinge offers pharmaceutical isolators, sterilization equipment, and infection control solutions for life sciences and healthcare, overlapping with Bioquell's Qube isolator and ProteQ decontamination systems serving GMP-regulated manufacturers and hospitals.

TypeDirect peer
Description

Steris is the most direct competitor, offering Vaporized Hydrogen Peroxide (VHP) bio-decontamination systems alongside a much broader sterilization, infection prevention, and lab equipment portfolio serving the same pharmaceutical, biotech, and healthcare customers as Bioquell.

TypeBroad incumbent
Description

Halma is a UK-listed group of safety and environmental technology companies with several subsidiaries in life sciences decontamination, gas detection, and process analytics; relevant as a comparable diversified industrial safety conglomerate with bio-decontamination adjacencies.

TypeEmerging player
Description

ClorDiSys specializes in chlorine dioxide gas decontamination for cleanrooms, laboratories, and BSL-3/4 facilities, providing an alternative bio-decontamination chemistry to Bioquell's hydrogen peroxide vapor in comparable life sciences and healthcare applications.

TypeDirect peer
Description

Fedegari manufactures autoclaves, washer-disinfectors, and bio-decontamination systems (including vaporized H2O2 platforms) for pharmaceutical and hospital customers, positioning it as a direct comparable for Bioquell's equipment line.

TypeEmerging player
Description

Shinva is a Chinese sterilization and infection control equipment manufacturer with growing international presence, competing in the same low-temperature bio-decontamination and sterilizer categories relevant to Bioquell's APAC strategy.

TypeEmerging player
Description

Tuttnauer manufactures autoclaves, plasma sterilizers, and laboratory decontamination equipment for pharma, research, and healthcare — a partial-overlap competitor in sterilization and bio-decontamination categories where Bioquell competes.

TypeDirect peer
Description

SKAN is a leading pharmaceutical isolator specialist with ~30% market share, directly comparable to Bioquell Qube and competing for sterility testing, gene/cell therapy, and aseptic manufacturing installations in regulated GMP environments.

TypeDirect peer
Description

Tomi offers SteraMist, an ionized Hydrogen Peroxide vapor decontamination technology, directly competing with Bioquell HPV across pharmaceutical, healthcare, and biosafety applications with a focus on surface and room decontamination.

TypeBroad incumbent
Description

Belimed provides infection control and sterilization equipment for hospitals and life sciences, with overlapping reach into pharma decontamination and CSSD markets where Bioquell competes.

Market position
Strengths1 record

Each record includes

Headline, Details, Source

Weaknesses5 records

Each record includes

Headline, Details, Source

Competitive moat5 records

Each record includes

Type, Details

Key risks6 records

Each record includes

Headline, Details, Source

Key highlights7 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Named customers2 records

Each record includes

Name, Industry, Type, Use case, Source, UUID

Segment5 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile4 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
Yes
API detail
Has APIbool
No

Docs URL, Description

Integration3 records

Each record includes

Title, Type, Description, Source

AI maturity
App detail

Has app

Feature9 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles1 record

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

Subsidiaries8 records

Each record includes

Name, Acquired on, Relationship type, Type, Business focus

Compliance5 records

Each record includes

Name, Class, Description

Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Bioquell

Bio-decontamination Equipmentbioquell.com

Bioquell designs, manufactures, and services Hydrogen Peroxide Vapor (HPV) bio-decontamination systems, isolators, and on-site decontamination services for pharmaceutical manufacturing, biotechnology, gene and cell therapy, hospital infection control, and life sciences research, operating as a wholly-owned subsidiary of Ecolab Inc.

What Bioquell does

Bioquell designs, manufactures, and services bio-decontamination systems based on proprietary 35% Hydrogen Peroxide Vapor (HPV) technology. The HPV process is a four-stage cycle (Preparation, Vaporization, Dwell, Aeration) that achieves a validated 6-log sporicidal kill on exposed surfaces while leaving no residue, allowing equipment to be immediately operational without post-cycle wipe-down. Bioquell's product range includes mobile and fixed HPV generators (ProteQ, L-4, IG-2, SeQure), the customizable Qube polypropylene pharmaceutical isolator with a 16-week install/validation cycle, and the Integrated Building Decontamination System (IBDS) for centralized facility-level decontamination via HVAC distribution and BMS integration. The portfolio is EPA-registered, BPR-compliant, GMP-aligned, and supports 21 CFR Part 11 audit trails, with consumables (RFID-tagged 35% hydrogen peroxide sterilant and in-house Geobacillus stearothermophilus biological indicators) sold alongside the hardware estate.

Bioquell serves pharmaceutical manufacturing and compounding, biotechnology and drug development, gene and cell therapy, hospitals and patient care, and research laboratories. End users include pharma manufacturers operating GMP/GLP cleanrooms, advanced therapy manufacturers handling cell and gene material, and NHS hospitals using the service for infection prevention and outbreak response. The company also publishes over 50 peer-reviewed references and offers a free contamination control webinar series targeting cell and gene therapy manufacturers.

The business operates three revenue streams: (1) equipment and systems sales (ProteQ, Qube, SeQure, L-4, IG-2, IBDS); (2) recurring consumables (hydrogen peroxide sterilant, biological and chemical indicators); and (3) professional services including the Rapid Bio-Decontamination Service (RBDS) for on-site managed decontamination and validation services (IQ/OQ, customized cycle development). Go-to-market is enterprise field sales via wholly-owned subsidiaries in seven countries (UK, USA, France, Germany, Ireland, China, Singapore) under the Ecolab Life Sciences brand, complemented by the QuAD Quality Assurance Data Portal for digital cycle and compliance documentation. Bioquell is a wholly-owned subsidiary of Ecolab Inc., and pricing is not publicly disclosed — customers are directed to regional sales teams for quotes.

Bioquell firmographics

Firmographics
Name
Bioquell
Legal name
Bioquell Group (Bioquell PLC)
Website
https://bioquell.com
Company type
Private
Founded year
2003
Operating status
Operating
Headcount range
251–500 employees
Short description
Bioquell designs, manufactures, and services Hydrogen Peroxide Vapor (HPV) bio-decontamination systems, isolators, and on-site decontamination services for pharmaceutical manufacturing, biotechnology, gene and cell therapy, hospital infection control, and life sciences research, operating as a wholly-owned subsidiary of Ecolab Inc.
Ownership category
akta.pro rank

Bioquell industry classification

Industry
Product category
Bio-decontamination Equipment
NAICS
Irradiation Apparatus Manufacturing (334517)
SIC
Surgical & Medical Instruments & Apparatus (3841)
akta.pro primary industry
Bioprocess Safety, Biosafety & Contamination Control Solutions (single-use integrity, environmental monitoring) (HLAAAJAO)
akta.pro secondary industries
Bioprocess Consumables & Reagents (resins, membranes, media components, buffers) (HLAAAJAI), Infectious Disease/Pathogen Decontamination (HSAEAHAF), Biohazard Spill Response & Decontamination Services (BPALAGAH)

Keywords

  • Hydrogen peroxide vapor
  • Bio-decontamination systems
  • Pharmaceutical contamination control
  • Cleanroom decontamination services
  • Aseptic manufacturing solutions

Where Bioquell is headquartered

Location

Headquarters

HQ city
Andover
HQ country
United Kingdom
HQ region
Europe

Offices7 records

Markets served

Bioquell business model

Business model
GTM type
B2B
Offering type
Hardware or Manufacturing
Cost components
Personnel, Supply Chain, Technology or R&D, Operations, Marketing or Sales, Infrastructure

Revenue model

  1. Equipment and Systems Sales: Sale of Bioquell HPV decontamination systems including ProteQ, Qube, SeQure, L-4, IG-2, and Integrated Building Decontamination Systems. Systems are sold directly to pharmaceutical, life sciences, and healthcare facilities.
  2. Rapid Bio-Decontamination Service (RBDS): On-site decontamination services provided by skilled Bioquell personnel for facilities that do not have resources, time, or equipment. Service includes full reporting with biological and chemical indicator results.
  3. Consumables: Hydrogen peroxide sterilant (35% concentration with RFID tagging), biological indicators, and chemical indicators for use with Bioquell systems. Consumables are provided in traceable bottles with certificates of analysis.

Go-to-market motion1 record

Distribution channels3 records

Marketing channels4 records

Bioquell product offering

Product offering

Core offering

Bioquell designs, manufactures and services bio-decontamination systems based on its proprietary 35% Hydrogen Peroxide Vapor (HPV) technology, including the ProteQ mobile unit, Qube pharmaceutical isolator, SeQure, L-4, IG-2, and Integrated Building Decontamination Systems. The company also delivers the on-site Rapid Bio-Decontamination Service (RBDS) using HPV and supplies consumables (biological indicators, chemical indicators and hydrogen peroxide sterilant) plus validation services for pharmaceutical, life sciences and healthcare facilities.

Product overview

Bioquell, an Ecolab company, provides a comprehensive hydrogen peroxide vapor (HPV) bio-decontamination portfolio consisting of proprietary 35% Hydrogen Peroxide Vapor technology as the core platform, supported by multiple product systems (ProteQ mobile unit, Qube isolator, SeQure fixed system, L-4 and IG-2 generators, and Integrated Building Decontamination System) and the Rapid Bio-Decontamination Service (RBDS) for managed on-site decontamination. The portfolio includes complementary consumables (biological/chemical indicators, hydrogen peroxide sterilant), validation services, and the QuAD data management portal. Products serve pharmaceutical manufacturing, life sciences R&D, healthcare, and biotech applications with EPA registration and BPR compliance.

Differentiator

Problem solved

Functional benefit

Brands

  • Bioquell Qube: Pharmaceutical isolator integrated with Hydrogen Peroxide Vapor technology for sterility testing, gene & cell therapy, small batch production, compounding, and cytotoxic preparation
  • Bioquell ProteQ
  • Bioquell SeQure
  • Bioquell L-4
  • Bioquell IG-2
  • Bioquell RBDS
  • Bioquell IBDS
  • Bioquell HPV-AQ

Products and services

  • Bioquell ProteQ Mobile, scalable Hydrogen Peroxide Vapor generator with wireless communication technology. All components including aeration are hosted within the frame for simple setup. Designed for biopharmaceutical manufacturing areas, production labs, room and zone decontamination, bio-safety labs, cleanrooms, and GMP/GLP laboratories.
  • Bioquell Qube Pharmaceutical Isolator Customizable pharmaceutical isolator integrated with Hydrogen Peroxide Vapor technology. Constructed from polypropylene (not stainless steel) for quick installation and validation within 16 weeks. Used for sterility testing, gene and cell therapy, small batch production, compounding, and cytotoxic preparation.
  • Bioquell SeQure Fixed, wall-mounted bio-decontamination system for pass-throughs, material airlocks, lab and room decontamination, and spaces smaller than 150 cubic meters. Designed for viral and bacterial vector work, biosecurity and small research areas.
  • Bioquell L-4 Versatile, multipurpose Hydrogen Peroxide Vapor generator for enclosed systems and equipment up to larger rooms and spaces (up to 250 cubic meters with optional distribution head). Compatible with isolators, RABS, freeze dryers, bio-safety cabinets, cage and rack washers, incubators, and filter bank enclosures.
  • Bioquell IG-2 System integration solution for RABS, filling lines, cage and rack washers, robotic enclosures, material airlocks, and small-volume rooms. Offers remote-control screen and 21 CFR Part 11 audit trail compliance for electronic records.
  • Bioquell Integrated Building Decontamination System (IBDS) Fully integrated, centralized bio-decontamination solution designed for frequent or routine decontamination of the same area. Equipment is located in unclassified area with vapor distributed through building HVAC or dedicated pipe network, controlled via Building Management System (BMS) integration. Validated 6-log sporicidal kill for GMP biopharmaceutical manufacturing, filling suites, biomedical facilities and biosafety laboratories.
  • Rapid Bio-Decontamination Service (RBDS) On-site managed decontamination service delivered by trained Bioquell personnel using Hydrogen Peroxide Vapor. Available for spaces from smallest enclosures to large buildings, including BSL-2/3/4 labs, post-construction commissioning, pharmaceutical production and emergency containment. Includes full reporting with biological and chemical indicators confirming 6-log sporicidal kill, cycle parameters, and environmental conditions.
  • Bioquell Biological Indicators In-house manufactured biological indicators using Geobacillus stearothermophilus endospores with over one million spores per carrier disc. Available in boxes of 20 or 100 with re-sealable wallets of 20 each for cycle validation in Bioquell decontamination systems.
  • Bioquell Chemical Indicators In-house manufactured chemical indicators with reactive dye that changes color when exposed to Hydrogen Peroxide Vapor, providing real-time cycle success indication. Available in boxes of 20 or 100 for use with Bioquell decontamination systems.
  • Bioquell Hydrogen Peroxide Sterilant (HPV-AQ) 35% hydrogen peroxide sterilant solution (EPA Registration Number: 72372-1-86703) supplied in RFID-tagged bottles for traceability, volume tracking, GMP documentation and cycle reproducibility with Bioquell decontamination systems.
  • Bioquell Validation Services Professional validation, maintenance and customer service support including Installation and Operational Qualification (IQ/OQ), customized cycle development, and regulatory compliance verification for Bioquell decontamination systems installed at customer sites.

Quantifiable outcome

  • 99.9999% pathogen reduction (6-log kill) on all exposed surfaces
  • +2 more outcomes

Companies that use Bioquell

Customer profile

Named customers2 records

Segments5 records

Ideal customer profiles4 records

Bioquell technology and API

Technology

Technology focussed Yes

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Integration3 records

Feature9 records

Bioquell partnerships and signals

Strategic signal

Partnerships

One partnership is on record.

  • EcolabflagshipStrategic or Co-development PartnerBioquell is a subsidiary of Ecolab Inc., operating under the Ecolab Life Sciences division. The partnership provides Bioquell with Ecolab's global distribution network, resources, and integration into a broader contamination control portfolio. Bioquell technology is marketed as part of Ecolab Life Sciences Complete Solutions.

Scale indicators3 records

Recent moves6 records

Expansion highlights6 records

Bioquell competitors and assessment

Company assessment

Broad incumbents

  • Getinge: Getinge offers pharmaceutical isolators, sterilization equipment, and infection control solutions for life sciences and healthcare, overlapping with Bioquell's Qube isolator and ProteQ decontamination systems serving GMP-regulated manufacturers and hospitals.
  • Halma plc: Halma is a UK-listed group of safety and environmental technology companies with several subsidiaries in life sciences decontamination, gas detection, and process analytics; relevant as a comparable diversified industrial safety conglomerate with bio-decontamination adjacencies.
  • Belimed (Metall Zug): Belimed provides infection control and sterilization equipment for hospitals and life sciences, with overlapping reach into pharma decontamination and CSSD markets where Bioquell competes.

Direct peers

  • Steris plc: Steris is the most direct competitor, offering Vaporized Hydrogen Peroxide (VHP) bio-decontamination systems alongside a much broader sterilization, infection prevention, and lab equipment portfolio serving the same pharmaceutical, biotech, and healthcare customers as Bioquell.
  • Fedegari Group: Fedegari manufactures autoclaves, washer-disinfectors, and bio-decontamination systems (including vaporized H2O2 platforms) for pharmaceutical and hospital customers, positioning it as a direct comparable for Bioquell's equipment line.
  • SKAN AG: SKAN is a leading pharmaceutical isolator specialist with ~30% market share, directly comparable to Bioquell Qube and competing for sterility testing, gene/cell therapy, and aseptic manufacturing installations in regulated GMP environments.
  • Tomí Environmental Solutions: Tomi offers SteraMist, an ionized Hydrogen Peroxide vapor decontamination technology, directly competing with Bioquell HPV across pharmaceutical, healthcare, and biosafety applications with a focus on surface and room decontamination.

Emerging players

  • ClorDiSys Solutions: ClorDiSys specializes in chlorine dioxide gas decontamination for cleanrooms, laboratories, and BSL-3/4 facilities, providing an alternative bio-decontamination chemistry to Bioquell's hydrogen peroxide vapor in comparable life sciences and healthcare applications.
  • Shinva Medical Instrument: Shinva is a Chinese sterilization and infection control equipment manufacturer with growing international presence, competing in the same low-temperature bio-decontamination and sterilizer categories relevant to Bioquell's APAC strategy.
  • Tuttnauer: Tuttnauer manufactures autoclaves, plasma sterilizers, and laboratory decontamination equipment for pharma, research, and healthcare — a partial-overlap competitor in sterilization and bio-decontamination categories where Bioquell competes.

Market position

Strengths1 record

Weaknesses5 records

Competitive moat5 records

Key risks6 records

Key highlights7 records

Customer concentration

Bioquell social profiles

Digital presence

Bioquell compliance and trust

Trust signal

Compliance5 records

Bioquell financial estimates

Financial estimate

Revenue estimate

Valuation estimate

Bioquell leadership team

Management profile

Number of profiles

Profiles1 record

Bioquell subsidiaries and ownership

Company hierarchy

Subsidiaries8 records

Bioquell funding detail

Funding detail

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

Bioquell M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Bioquell

What does Bioquell do?

Bioquell designs, manufactures and services bio-decontamination systems based on its proprietary 35% Hydrogen Peroxide Vapor (HPV) technology, including the ProteQ mobile unit, Qube pharmaceutical isolator, SeQure, L-4, IG-2, and Integrated Building Decontamination Systems. The company also delivers the on-site Rapid Bio-Decontamination Service (RBDS) using HPV and supplies consumables (biological indicators, chemical indicators and hydrogen peroxide sterilant) plus validation services for pharmaceutical, life sciences and healthcare facilities.

Is Bioquell a public or private company?

Bioquell is a private company. It is classified as corporate owned and is currently operating.

When was Bioquell founded?

Bioquell was founded in 2003. It employs 251 to 500 people.

Where is Bioquell based?

Bioquell is headquartered in Andover, United Kingdom, in the Europe region.

How does Bioquell make money?

Three revenue lines are on record. Equipment and Systems Sales are the primary driver. The others are rapid Bio-Decontamination Service (RBDS) and consumables.

Who are Bioquell's main competitors?

Broad incumbents on record are Getinge, Halma plc and Belimed (Metall Zug). Direct peers are Steris plc, Fedegari Group, SKAN AG and Tomí Environmental Solutions. Emerging players are ClorDiSys Solutions, Shinva Medical Instrument and Tuttnauer.

Does Bioquell have an API?

No public API is recorded for Bioquell.

What industry is Bioquell in?

Bioquell's product category is Bio-decontamination Equipment. Its primary akta.pro industry code is HLAAAJAO, Bioprocess Safety, Biosafety & Contamination Control Solutions (single-use integrity, environmental monitoring), with a secondary code of HLAAAJAI, Bioprocess Consumables & Reagents (resins, membranes, media components, buffers). Its NAICS code is 334517 and its SIC code is 3841.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals
Cleanroom TechnologyCapping in isolationWatson-Marlow Flexicon supplied two high-specification FPC50 aseptic filling and plugging systems to a UK-based biotherapeutic products manufacturer for its new clinical trials facility. The systems are integrated with isolators built by Extract Technology and utilize Bioquell UK's Clarus L HPV generator for automated decontamination.GlobeNewswireHydrogen Peroxide Chemical Indicator Market to Reach USD 56.1 Million by 2028; Bioquell’s Room Chemical Indicator to Boost Market, Says Fortune Business Insights™The global hydrogen peroxide chemical indicator market is projected to reach USD 56.1 million by 2028, up from USD 31.2 million in 2020, at a CAGR of 7.7%. Hospitals and surgery centers are expected to hold the largest share, driven by sterilization needs amid COVID-19.PR NewswireThe disinfectant robot market is expected to register a CAGR of 36.4% during the forecast period (2020-2025The global disinfectant robot market is projected to grow from USD 341.3 million in 2019 to USD 2,325.4 million by 2025, registering a CAGR of 36.4%, driven by rising demand for hygiene across sectors and the COVID-19 pandemic. Hospital-acquired infections (HAIs) are a significant driver, with the US CDC reporting 1 in 25 patients acquiring infections and 75,000 deaths annually from HAIs. Key companies including Blue Ocean Robotics, UVD Robots, Xenex, and Bioquell are expanding operations, while startups like Solubots, SESTO Robotics, and Vanora Robots have launched products to address this growing market.PR NewswireBGL Announces the Sale of Bioquell to EcolabBrown Gibbons Lang & Company announced the sale of Bioquell PLC to Ecolab Inc., with BGL serving as exclusive financial advisor to Bioquell in the transaction. Ecolab acquired 100% of Bioquell's outstanding shares for approximately £139 million ($178 million), subject to final share count determination. Bioquell, a UK-headquartered provider of hydrogen peroxide vapor bio-decontamination systems and services, is expected to broaden Ecolab's portfolio of products, services, and solutions for cleanrooms and high-grade environments.GlobeNewswireForm 8.3 - [Bioquell plc]Hargreave Hale disclosed a 1.8968% stake in Bioquell plc, holding 424,000 ordinary shares. The disclosure was made on 3 December 2018, with no dealings recorded.GlobeNewswireRathbones : Form 8.3 - Bioquell PlcRathbone Brothers Plc filed a Form 8.3 disclosure for Bioquell Plc, reporting a total holding of 895,589 shares (3.90%) after a sale of 47,000 shares on 5 July 2016. The disclosure also notes an undisclosed discretionary holding of 665,869 shares was aggregated, and eight prior trades were not reported.GlobeNewswireRathbones : Form 8.3 - Bioquell PlcRathbone Brothers Plc disclosed its positions in Bioquell Plc under the Takeover Code, holding 895,589 ordinary shares (3.90%) and selling 47,000 shares on 5 July 2016. The disclosure also lists prior sales in February and April 2016.PR NewswireHPV Decontamination Systems Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast 2016 - 2024This is a market research report analyzing the global hydrogen peroxide vapor (HPV) decontamination systems market for the period 2014–2024, published by Reportlinker in May 2015. The report covers market trends, drivers, restraints, and opportunities across applications including incubators, autoclaves/cage washers, isolators, and rooms/facilities, segmented by geography (North America, Europe, Asia Pacific, Middle East & Africa, and Latin America). Europe is identified as the dominant regional market due to major infection outbreaks such as Ebola in 2014 and technological advancements. The report profiles key industry players including Bioquell, Steris Corporation, Getinge Group, and others.